Boai NKY Pharmaceuticals Ltd (300109) — Strategic Asset Allocation Index
Boai NKY Pharmaceuticals Ltd (300109) has a Strategic Asset Allocation Index of 28.6% as of June 2023. Strategic assets (PP&E of CN¥926.45 Million plus long-term investments of CN¥-) total CN¥926.45 Million, measured against net assets of CN¥3.24 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Boai NKY Pharmaceuticals Ltd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Boai NKY Pharmaceuticals Ltd Strategic Asset Allocation Index (2007–2022)
This chart shows how Boai NKY Pharmaceuticals Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of June 2023, the index stands at 28.6%, representing strategic assets of CN¥926.45 Million against net assets of CN¥3.24 Billion CNY. For live market cap and overall valuation, see Boai NKY Pharmaceuticals Ltd (300109) market capitalisation.
Annual Strategic Asset Allocation Index for Boai NKY Pharmaceuticals Ltd (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Boai NKY Pharmaceuticals Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Boai NKY Pharmaceuticals Ltd net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 27.1% | CN¥844.80 Million | CN¥844.80 Million | CN¥- | CN¥3.12 Billion | ▲ +5.6 pp |
| 2021 | 21.5% | CN¥731.25 Million | CN¥731.25 Million | CN¥- | CN¥3.40 Billion | ▲ +1.6 pp |
| 2020 | 19.9% | CN¥610.95 Million | CN¥610.95 Million | CN¥- | CN¥3.08 Billion | ▲ +1.2 pp |
| 2019 | 18.7% | CN¥569.55 Million | CN¥569.55 Million | CN¥- | CN¥3.05 Billion | ▼ -20.8 pp |
| 2018 | 39.5% | CN¥503.91 Million | CN¥503.91 Million | CN¥- | CN¥1.28 Billion | ▲ +5.3 pp |
| 2017 | 34.2% | CN¥445.61 Million | CN¥445.61 Million | CN¥- | CN¥1.30 Billion | ▲ +4.8 pp |
| 2016 | 29.4% | CN¥360.22 Million | CN¥360.22 Million | CN¥- | CN¥1.23 Billion | ▲ +0.2 pp |
| 2015 | 29.1% | CN¥338.64 Million | CN¥338.64 Million | CN¥- | CN¥1.16 Billion | ▼ -44.1 pp |
| 2014 | 73.2% | CN¥292.89 Million | CN¥292.89 Million | CN¥- | CN¥400.25 Million | ▼ -3.4 pp |
| 2013 | 76.6% | CN¥288.77 Million | CN¥288.77 Million | CN¥- | CN¥377.06 Million | ▲ +5.7 pp |
| 2012 | 70.8% | CN¥257.74 Million | CN¥257.74 Million | CN¥- | CN¥363.81 Million | ▲ +21.8 pp |
| 2011 | 49.0% | CN¥171.97 Million | CN¥171.97 Million | CN¥- | CN¥350.93 Million | ▲ +29.7 pp |
| 2010 | 19.3% | CN¥64.29 Million | CN¥64.29 Million | CN¥- | CN¥333.21 Million | ▼ -32.0 pp |
| 2009 | 51.2% | CN¥31.84 Million | CN¥31.84 Million | CN¥- | CN¥62.14 Million | ▲ +1.8 pp |
| 2008 | 49.4% | CN¥21.71 Million | CN¥21.71 Million | CN¥- | CN¥43.93 Million | ▼ -38.3 pp |
| 2007 | 87.7% | CN¥15.63 Million | CN¥15.63 Million | CN¥- | CN¥17.82 Million | — |